APA (7th ed.) Citation

SL, J., P, C., H, T., C, Z., Z, L., Y, W., . . . Y, X. (2026). High-Throughput Screening Reveals That CeeNU Acts as a New NLRP3 Inflammasome Inhibitor. MedComm, 7, e70695. https://doi.org/10.1002/mco2.70695

Chicago Style (17th ed.) Citation

SL, Ji, et al. "High-Throughput Screening Reveals That CeeNU Acts as a New NLRP3 Inflammasome Inhibitor." MedComm 7 (2026): e70695. https://doi.org/10.1002/mco2.70695.

MLA (9th ed.) Citation

SL, Ji, et al. "High-Throughput Screening Reveals That CeeNU Acts as a New NLRP3 Inflammasome Inhibitor." MedComm, vol. 7, 2026, p. e70695, https://doi.org/10.1002/mco2.70695.